Coronavirus: The latest Israeli data proves vaccines work – 0.1% infected

Less than 0.1% of individuals who received their second dose of Pfizer vaccine contracted the disease, according to data released by Maccabi Healthcare Services on Thursday night.
According to the data, the vaccine effectiveness in Israel is now 93%. The Pfizer vaccine has been shown to be 95% effective in its Phase III clinical trials.

The report showed that only 544 people were infected from the data found until February 11, when a week has passed since 523,000 people received their second shot.

“The data unequivocally prove that the vaccine is very effective and we have no doubt that it saved the lives of many Israelites,” said Dr. Miri Mizrahi Reuveni, head of Maccabi’s health department, said.

No one who was vaccinated is dead. In addition, the majority of those who contracted the virus had only mild or no symptoms.

“Of the 544 infected, only 15 people need hospitalization,” the report said, “of which four were defined as serious, three in moderate and eight mild.”

At the same time, Maccabi conducted a random test among its non-vaccinated clients and found that 18,425 of 628,000 members with different profiles contracted coronavirus during the same period – 2.9%.

“As there are active diseases among children and adolescents up to 16 years of age that cannot be vaccinated, and the mutations of the virus are much more contagious, this means that anyone who is not vaccinated will be infected sooner or later,” he said. Mizrahi Reuveni said. dispute. ‘Hurry up and make an appointment as soon as possible. Protect yourself from a serious illness and, God forbid, from death, as well as the possibility that you will infect and endanger others. ‘

To date, Maccabi has vaccinated more than one million members with at least one dose of Pfizer coronavirus vaccine. The country has vaccinated more than 3.7 million, of which nearly 2.4 million were included with their second shot.

Eran Segal, a computational biologist at the Weizmann Institute of Science, reported on Thursday that since the peak of illness in mid-January, there has been a 38% decrease in the number of patients in serious condition and a 40% decrease in the number of deaths among the population older than 60 years.

He also said there are 58% fewer new elderly patients, and 44% fewer hospitalizations in general.

“About three weeks ago, they started receiving their second dose of vaccine,” Segal wrote.

Source